AIL
REGN icon

AGF Investments LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

AGF Investments LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-42
Closed -$25K – 388
2022
Q2 		$25K Sell
42
-95
-69% -$61.8K ﹤0.01% 331
2022
Q1 		$96K Sell
137
-380
-74% -$240K 0.01% 321
2021
Q4 		$326K Sell
517
-118
-19% -$72.5K 0.03% 272
2021
Q3 		$384K Sell
635
-40
-6% -$24.8K 0.04% 253
2021
Q2 		$377K Sell
675
-1,317
-66% -$667K 0.04% 256
2021
Q1 		$942K Sell
1,992
-366
-16% -$178K 0.11% 43
2020
Q4 		$1.14M Sell
2,358
-859
-27% -$464K 0.14% 42
2020
Q3 		$1.8M Sell
3,217
-1,502
-32% -$911K 0.2% 34
2020
Q2 		$2.94M Buy
4,719
+2,022
+75% +$1.15M 0.3% 35
2020
Q1 		$1.32M Sell
2,697
-770
-22% -$318K 0.17% 72
2019
Q4 		$1.3M Sell
3,467
-147
-4% -$49.5K 0.24% 116
2019
Q3 		$1M Sell
3,614
-926
-20% -$274K 0.24% 106
2019
Q2 		$1.42M Buy
+4,540
New +$1.51M 0.3% 100
2019
Q1 		– Sell
-1,197
Closed -$447K – 726
2018
Q4 		$447K Buy
1,197
+245
+26% +$89.7K 0.06% 237
2018
Q3 		$384K Buy
952
+10
+1% +$3.81K 0.05% 249
2018
Q2 		$326 Buy
942
+825
+705% +$258K 0.04% 262
2018
Q1 		$35K Buy
+117
New +$40.7K 0.01% 362

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AGF Investments LLC's REGN Position: Q3 2022 in Review

AGF Investments LLC sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 42 shares — an estimated $25K sold.

AGF Investments LLC first reported a position in REGN in Q1 2018 and held it in 17 quarters. The position peaked at $2.94M in Q2 2020. 1,081 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

  • AGF Investments LLC reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • AGF Investments LLC sold 42 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $25K.
  • AGF Investments LLC first reported a position in Regeneron Pharmaceuticals in Q1 2018 and held it in 17 quarters.
  • AGF Investments LLC's Regeneron Pharmaceuticals position peaked at $2.94M in Q2 2020.
  • 1,081 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.